Dow Down0.17% Nasdaq Down0.28%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
9.10 0.35(3.70%) Sep 30, 4:15PM EDT
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate-0.14-0.13-0.61-0.29
No. of Analysts8.008.009.009.00
Low Estimate-0.20-0.19-0.74-0.57
High Estimate-0.04-0.04-0.440.13
Year Ago EPS-0.17-0.19-0.74-0.61
Revenue EstCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate16.47M18.85M65.92M103.11M
No. of Analysts7788
Low Estimate12.90M14.30M58.60M74.60M
High Estimate19.60M24.20M74.20M145.30M
Year Ago Sales16.01M12.50M54.80M65.92M
Sales Growth (year/est)2.80%50.80%20.30%56.40%
Earnings HistorySep 13Dec 13Mar 14Jun 14
EPS Est-0.15-0.17-0.14-0.14
EPS Actual-0.17-0.19-0.22-0.13
Difference-0.02-0.02-0.080.01
Surprise %-13.30%-11.80%-57.10%7.10%
EPS TrendsCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Current Estimate-0.14-0.13-0.61-0.29
7 Days Ago-0.14-0.13-0.62-0.29
30 Days Ago-0.14-0.13-0.62-0.29
60 Days Ago-0.13-0.12-0.60-0.28
90 Days Ago-0.12-0.11-0.58-0.25
EPS RevisionsCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Up Last 7 Days0111
Up Last 30 Days0112
Down Last 30 Days1000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstHALOIndustrySectorS&P 500
Current Qtr.17.60%N/A-78.90%13.80%
Next Qtr.31.60%N/A-65.10%23.70%
This Year17.60%9.80%46.20%7.60%
Next Year52.50%14.00%34.70%13.00%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A15.04%16.24%10.09%
Price/Earnings (avg. for comparison categories)-14.923.675.9225.89
PEG Ratio (avg. for comparison categories)N/A0.718.432.14
Currency in USD.